Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial
Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Anne-Aurore Duchambon, Vincent Huberlant(Centre Hospitalier Universitaire de Nantes), Damien Contou(Seoul National University Hospital), Julien Pottecher(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), Oliver Hartmann, Constance Vuillard(Hôpital Louis-Mourier), Julie Helms(Inserm), Suzanne Renard, Peter Pickkers(Radboud University Nijmegen), Pierre Asfar(Centre Hospitalier Universitaire d'Angers), Gaëtan Plantefève(Centre Hospitalier Victor Dupouy), Haikel Oueslati(Radboud University Nijmegen), Andreas Bergmann(Agostino Gemelli University Polyclinic), Thomas Daix, Tobias Schuerholz(RWTH Aachen University), Thierry Dugernier(Clinique Saint Pierre), Marine Goudelin(Inserm), Bruno Evrard(Centre Hospitalier Universitaire de Clermont-Ferrand), Melanie Pars, Jean-Claude Lachérade(Roche (France)), Christine Collienne, Gernot Marx(RWTH Aachen University), Philippe G. Jorens(University of Antwerp), Kathleen M. Richter, Michael Bauer(Jena University Hospital), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Albertus Beishuizen(Medisch Spectrum Twente), Diego Castanares‐Zapatero(Cliniques Universitaires Saint-Luc), Jean-Baptiste Lascarrou(Centre Hospitalier Universitaire de Nantes), Thomas Godet(Centre Hospitalier Universitaire de Clermont-Ferrand), Benjamin G. Chousterman(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Virginie Montiel, Mahir Karakas(Universität Hamburg), Emmanuel Weiss, Anne-Laure Fedou, Caroline Berghe, Bruno François(Inserm), Jens Zimmermann, Ferhat Meziani(Université de Strasbourg), Leslie Gielens, Arnaud Desachy, Philippe Vignon(Université de Limoges), Ludovic Gèrards, M Dujardin, Jacques Duranteau(Assistance Publique – Hôpitaux de Paris), Phillipe Hantson, Oscar Hoiting(Canisius-Wilhelmina Ziekenhuis)
Cited by 92
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k